Fullerton Health Group

Fullerton Health is an integrated enterprise healthcare service provider founded in 2010 in Singapore.[1] The company specializes in designing customized medical services for corporate and insurer clients.[2]

Starting in 2011 Fullerton has expanded its presence to Malaysia, Indonesia, and Hong Kong[1] As of 2022 it had operations in nine countries in Asia-Pacific.[3]

History

Fullerton Health began with an initial investment in corporate healthcare providers Gethin-Jones and Drs Trythall Hoy Davies.[1] Over the years, it has grown both organically and through mergers and acquisitions.[4] It now now operates with a staff of close to 400 medical professionals and over 1,000 support staff[5] and a network of over 8,000 associate hospitals and clinics.[1]

By 2014, Fullerton Health experienced more than double revenue growth to S$163.8 million followed by a 46.9% growth in 2015 to S$240.6 million.[6]

Fullerton Health made 3 major acquisitions in 2015 which helped grow its presence in both existing and new markets. In May, their subsidiary, Global Assistance & Healthcare (GAH) acquired PT JLT GESA, more commonly known as Medilum, that provides managed healthcare and third-party administration services.[7] Later in August, they bought an 80 percent stake in Hong Kong medical provider, HMMP Limited (HMMP), for SGD$33 million.[8] Above all, the purchase of Radlink-Asia in Singapore for SGD$111.2 million[9] marked its entry into the advanced medical diagnostic imaging market and allowed it to cut costs through the digitisation of processes.[10]

As of June 30, 2016, Fullerton Health owned 198 clinics and facilities across Singapore, Hong Kong, Indonesia, and Malaysia,[11] had close to 2,000 employees[12] and had annual revenue of more than S$300 million.[13] Fullerton Health received an average of 4 million patient visits per annum and claimed to have provided medical services to approximately 10 million people,[14] working with approximately 25,000 companies across Asia-Pacific.[15] Its corporate clientele include Marina Bay Sands, Standard Chartered Bank, Singapore Airlines and other multinational corporation employees, as well as SME employees.[13]

The company sought new financing in 2021 which was nearly derailed by internal disagreements. The company's founders brought winding up proceedings which were evntually withdrawn.[6] In 2025 the company attracted investment from Mitsubishi Corp. as part of the Japanese company's regional healthcare expansion.[16][17][18]

In August 2025, David Sin, one of the co-founders of Fullerton Healthcare Corp (FHC) was fined $160,000 fine for approving falsified claims of over $213,000.[19] Sin approved the claims on multiple occasions in 2019, despite knowing that another co-founder Daniel Chan Pai Sheng, 51, had submitted them with the intent to defraud FHC, according to court documents.[20]